Ibex Investors LLC Kamada LTD Transaction History

Ibex Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$4.97 - $7.7 $414,751 - $642,572	-83,451 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$5.11 - $5.99 $971,947 - $1.14 Million	-190,205 Reduced 69.51%	83,451 $428,000
Q2 2019 Jul 29, 2019	SELL	$5.39 - $6.26 $185,399 - $215,325	-34,397 Reduced 11.17%	273,656 $1.51 Million
Q1 2019 May 07, 2019	BUY	$5.12 - $6.18 $271 - $327	53 Added 0.02%	308,053 $1.77 Million
Q4 2018 Feb 13, 2019	BUY	$4.68 - $6.25 $182,520 - $243,750	39,000 Added 14.5%	308,000 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$4.4 - $5.3 $61,600 - $74,200	14,000 Added 5.49%	269,000 $1.4 Million
Q1 2018 May 15, 2018	BUY	$4.6 - $5.75 $30,433 - $38,042	6,616 Added 2.66%	255,000 $1.17 Million
Q4 2017 Feb 14, 2018	BUY	$4.35 - $5.15 $1.08 Million - $1.28 Million	248,384	248,384 $1.18 Million

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $332M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.